Wire Stories

Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads

YOKOHAMA, Japan--(BUSINESS WIRE)--Nissan has commenced demonstrations of a prototype vehicle equipped with its in-house-developed, autonomous drive technologies - showcasing progress…

2 years ago

Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock

Exciting New Application from Intel Enables Fast PC-to-PC Connectivity TAIPEI, Taiwan--(BUSINESS WIRE)--#Intel--Other World Computing – the leading solution provider of…

2 years ago

Stronger Than Ever: Adani Portfolio Delivers Record Performance

45% EBITDA growth in FY24, EBITDA reaches USD 10 Bn Adani Portfolio EBITDA increased to USD 10 Bn, up by…

2 years ago

Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises

Integration enhances the Denodo Platform, providing enterprise customers with faster, more secure, and fully scalable AI capabilities PALO ALTO, Calif.--(BUSINESS…

2 years ago

Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI

At the office opening today, Ángel Viña, CEO of Denodo will be joined by Dr. Shaikha Dheya Bint Ebrahim Al…

2 years ago

ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy

DESTINY-Breast06 results show Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed medicine and antibody drug conjugate to demonstrate…

2 years ago

“Experience the Luxury of Japanese Tradition and Cuisine” Reservations for the New Inbound Experience Tour in Osaka’s Tondabayashi Begin on June 1, 2024!

OSAKA, Japan--(BUSINESS WIRE)--The city of Tondabayashi in Osaka is excited to announce a new inbound tour by "SABIWabisabi," aimed at…

2 years ago

Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma

− Four-year Analysis Conducted by GHSG Reported ADCETRIS + ECADD Combination Improved Progression-Free Survival, Showing Superior Efficacy and Tolerable Safety…

2 years ago

Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024

– Differentiated Mechanism of Action of a Chimeric Degrader as Compared to Fulvestrant and Novel SERDs – – Treatment with…

2 years ago

The World’s Light Painting Masters and GAC Work Together to Create a Chinese Giant Light-Painted Dragon That Shines in Dubai for the First Time

GUANGZHOU, China--(BUSINESS WIRE)--Coinciding with the Chinese Year of the Dragon in 2024, in order to celebrate the 40th anniversary of…

2 years ago